(P117) Clinical Outcomes in US Patients Initiating Finerenone – A Report from the FOUNTAIN Platform

Saturday, August 10, 2024

12:15 PM – 1:15 PM CT

Primary Presenter(s)

Leah Whitener, PharmD, BCPS

Senior Medical Science Liaison
Bayer Pharmaceuticals

This poster reviews a report from the FOUNTAIN Platform including patients with CKD and T2D from the US with documented initiation of finerenone through electronic health records.